Results 31 to 40 of about 137,019 (343)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series

open access: yesIndian Journal of Psychological Medicine, 2017
Opioid withdrawal is very rarely characterized by delirium unlike alcohol or benzodiazepine withdrawal. PubMed search through October 2016 reveals only two case series on delirium as feature of withdrawal in opioid dependence syndrome.
Sourav Das   +3 more
doaj   +1 more source

Shortening Anesthesia Duration does not Affect Severity of Withdrawal Syndrome in Patients Undergoing Ultra Rapid Opioid Detoxification [PDF]

open access: yesActa Medica Iranica, 2010
Ultra rapid opioid detoxification (UROD) is one of the new methods of detoxification. This method of detoxification involves putting patients under general anesthesia and actively giving them opioid antagonists.
Shoaleh Shami   +3 more
doaj   +2 more sources

Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Patterns [PDF]

open access: yes, 2014
In 1987, Cloninger proposed a clinical description and classification of different personality traits genetically defined and independent from each other. Moreover, he elaborated a specific test the TCI to investigate these traits/states.
Attilia, Maria Luisa   +9 more
core   +1 more source

The use of cannabidiol in addiction therapy in the light of clinical trials. [PDF]

open access: yesFarmacja Polska, 2020
Addiction is a chronic recurrent disorder characterized by substance abuse and withdrawal syndrome with "hunger." Cannabidiol (CBD), a non-psychoactive cannabinoid, is used to treat neurological conditions, including substance or behavioral addiction ...
Julia Alicja Lewandowska   +2 more
doaj   +1 more source

Withdrawal Success Estimation [PDF]

open access: yes, 2022
Given a geometric Levy alpha-stable wealth process, a log-Levy alpha-stable lower bound is constructed for the terminal wealth of a regular investing schedule. Using a transformation, the lower bound is applied to a schedule of withdrawals occurring after an initial investment.
arxiv   +1 more source

Is there a potential of misuse for venlafaxine and bupropion? [PDF]

open access: yes, 2018
© 2018 Schifano and Chiappini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the ...
Anderson   +64 more
core   +2 more sources

Problematisation and regulation: bodies, risk, and recovery within the context of Neonatal Abstinence Syndrome [PDF]

open access: yes, 2018
Background Neonatal Abstinence Syndrome (NAS) is an anticipated effect of maternal drug use during pregnancy. Yet it remains a contested area of policy and practice.
Chandler, Amy   +5 more
core   +3 more sources

The effects of Tranquival tablet on some heroin withdrawal symptoms

open access: yesChronic Diseases Journal, 2015
BACKGROUND: Individuals, during opioid withdrawal period, experience symptoms such as dysphoria, insomnia, anxiety, irritability, nausea, agitation, tachycardia, and hypertension which may trigger drug seeking behavior and relapse.
Masoud Nikfarjam   +3 more
doaj   +1 more source

Glowing Experience or Bad Trip? A Quantitative Analysis of User Reported Drug Experiences on Erowid.org [PDF]

open access: yesarXiv, 2022
Erowid.org is a website dedicated to documenting information about psychoactive substances, with over 36,000 user-submitted drug Experience Reports. We study the potential of these reports to provide information about characteristic experiences with drugs. First, we assess different kinds of drug experiences, such as 'addiction' or 'bad trips'.
arxiv  

Nicotine addiction : a review [PDF]

open access: yes, 2013
Nicotine, the major psychoactive compound in tobacco, acts as a potent addictive drug in humans. The addictive nature of nicotine leads to more than 6 million deaths a year.
Di Giovanni, Giuseppe, Vella, Jacob
core   +1 more source

Home - About - Disclaimer - Privacy